Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 3
1969 2
1970 1
1972 1
1982 1
1991 1
1995 1
1999 1
2000 4
2001 3
2002 1
2003 2
2004 3
2005 6
2006 5
2007 11
2008 3
2009 6
2010 8
2011 12
2012 11
2013 8
2014 5
2015 2
2016 12
2017 11
2018 8
2019 6
2020 7
2021 5
2022 9
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

153 results

Results by year

Filters applied: . Clear all
Page 1
Sipuleucel-T immunotherapy for castration-resistant prostate cancer.
Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, Redfern CH, Ferrari AC, Dreicer R, Sims RB, Xu Y, Frohlich MW, Schellhammer PF; IMPACT Study Investigators. Kantoff PW, et al. N Engl J Med. 2010 Jul 29;363(5):411-22. doi: 10.1056/NEJMoa1001294. N Engl J Med. 2010. PMID: 20818862 Free article. Clinical Trial.
Role of B cells as antigen presenting cells.
Rastogi I, Jeon D, Moseman JE, Muralidhar A, Potluri HK, McNeel DG. Rastogi I, et al. Among authors: mcneel dg. Front Immunol. 2022 Sep 8;13:954936. doi: 10.3389/fimmu.2022.954936. eCollection 2022. Front Immunol. 2022. PMID: 36159874 Free PMC article. Review.
Enzalutamide in metastatic prostate cancer before chemotherapy.
Beer TM, Armstrong AJ, Rathkopf DE, Loriot Y, Sternberg CN, Higano CS, Iversen P, Bhattacharya S, Carles J, Chowdhury S, Davis ID, de Bono JS, Evans CP, Fizazi K, Joshua AM, Kim CS, Kimura G, Mainwaring P, Mansbach H, Miller K, Noonberg SB, Perabo F, Phung D, Saad F, Scher HI, Taplin ME, Venner PM, Tombal B; PREVAIL Investigators. Beer TM, et al. N Engl J Med. 2014 Jul 31;371(5):424-33. doi: 10.1056/NEJMoa1405095. Epub 2014 Jun 1. N Engl J Med. 2014. PMID: 24881730 Free PMC article. Clinical Trial.
Vaccines as treatments for prostate cancer.
Rastogi I, Muralidhar A, McNeel DG. Rastogi I, et al. Among authors: mcneel dg. Nat Rev Urol. 2023 Sep;20(9):544-559. doi: 10.1038/s41585-023-00739-w. Epub 2023 Mar 6. Nat Rev Urol. 2023. PMID: 36879114 Free PMC article. Review.
Toll-like receptor agonists as cancer vaccine adjuvants.
Jeon D, Hill E, McNeel DG. Jeon D, et al. Among authors: mcneel dg. Hum Vaccin Immunother. 2024 Dec 31;20(1):2297453. doi: 10.1080/21645515.2023.2297453. Epub 2023 Dec 28. Hum Vaccin Immunother. 2024. PMID: 38155525 Free PMC article. Review.
First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Rα, as a single agent and in combination with spartalizumab in patients with advanced and metastatic solid tumors.
Leidner R, Conlon K, McNeel DG, Wang-Gillam A, Gupta S, Wesolowski R, Chaudhari M, Hassounah N, Lee JB, Ho Lee L, O'Keeffe JA, Lewis N, Pavlakis GN, Thompson JA. Leidner R, et al. Among authors: mcneel dg. J Immunother Cancer. 2023 Oct;11(10):e007725. doi: 10.1136/jitc-2023-007725. J Immunother Cancer. 2023. PMID: 37907221 Free PMC article. Clinical Trial.
DNA vaccines for prostate cancer.
Zahm CD, Colluru VT, McNeel DG. Zahm CD, et al. Among authors: mcneel dg. Pharmacol Ther. 2017 Jun;174:27-42. doi: 10.1016/j.pharmthera.2017.02.016. Epub 2017 Feb 7. Pharmacol Ther. 2017. PMID: 28185916 Free PMC article. Review.
Molecular Imaging of Immunotherapy Targets in Cancer.
Ehlerding EB, England CG, McNeel DG, Cai W. Ehlerding EB, et al. Among authors: mcneel dg. J Nucl Med. 2016 Oct;57(10):1487-1492. doi: 10.2967/jnumed.116.177493. Epub 2016 Jul 28. J Nucl Med. 2016. PMID: 27469363 Free PMC article. Review.
153 results